相关实验视频
Updated: Feb 4, 2026

07:14
Author Spotlight: Membrane Protein Reconstitution in Synthetic Cells
Published on: March 8, 2024
1.7K
在雷特综合征中剖析甲基胺基酸受体7表达:对药物治疗的后果
bioRxiv : the preprint server for biology
|June 4, 2025
概括
在有严重MECP2突变的雷特综合征患者中,甲本托普谷氨酸受体7 (mGlu7) 水平下降. 对mGlu7的阳性全调节器 (PAM) 减少了小鼠模型中的呼吸异常,表明了治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 雷特综合征是一种神经发育障碍,通常是由MECP2基因突变引起的.
- 在雷特综合征患者和Mecp2突变小鼠中观察到降低的甲本托普谷氨酸受体7 (mGlu7) 水平.
- 针对mGlu7的正基调制剂 (PAM) 在纠正行为缺陷方面表现有前途.
研究的目的:
- 在一个较大的雷特综合征 (RTT) 患者队列中研究III组甲本托普性谷氨酸受体 (mGlu4,mGlu7,mGlu8) 的表达.
- 为了将mGlu7表达水平与RTT中MECP2突变的严重程度相关联.
- 评估mGlu7 PAM在减轻轻轻度RTT的小鼠模型中的呼吸异常方面的疗效.
主要方法:
- 在RTT患者和对照患者的大脑样本中分析mGlu4,mGlu7和mGlu8mRNA表达.
- 基于突变严重程度和临床相关性对RTT患者的分层.
- 将mGlu7 PAM VU0422288 给Mecp2 ((R306C/+) 小鼠,以评估对呼吸暂停的影响.
- 在接受治疗的小鼠的大脑干和皮质中测量mGlu7表达.
主要成果:
- 在RTT患者中发现mGlu7mRNA表达显著下降,特别是那些患有严重MECP2突变的患者.
- 在RTT患者中没有观察到mGlu4或mGlu8mRNA表达的显著变化.
- 在对照个体中发现了mGlu4和mGlu8表达之间的强烈正相关性.
- 给予VU0422288显著减少Mecp2(R306C/+) 小鼠的呼吸暂停,无论基线mGlu7水平如何.
结论:
- mGlu7,但不是mGlu4或mGlu8,在具有严重MECP2突变的RTT患者中是下调的.
- mGlu7 PAMs显示出治疗雷特综合征中的呼吸功能障碍的潜力,例如呼吸暂停.
- mGlu7 PAMs的治疗疗效可能扩展到RTT患者,而没有显著的mGlu7下调.
更多相关视频
相关概念视频
Psychosis: Goals of Pharmacotherapy
536
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
536
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Timing and Consequences on Behavior
396
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective.
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
396
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Antiepileptic Drugs: Glutamate Antagonists
980
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
980
Receptor-mediated Endocytosis
110.9K
Overview
110.9K

